Comparing Thailand with Japan requires knowing which regulatory pathway and clinical product a provider is describing. A regenerative medicine plan, a research study and a marketed product are not interchangeable claims.
On this page
Regulatory questions for Japan
Japan’s framework distinguishes the provision of regenerative medicine from the approval of regenerative medical products. MHLW’s current notices also record amendments to the safety framework effective in 2025. Ask which pathway applies to the exact proposal rather than treating a registration number as a universal endorsement. Japan MHLW: regenerative medicine framework; Japan MHLW: regenerative medicine laws and notices.
Clarify what an approval statement refers to
Request the product or plan identifier, its authorised scope and any conditions attached to access. Ask whether the cited result concerns the same preparation and diagnosis. If a provider uses the phrase “conditional approval”, ask for the current product information and what evidence or monitoring remains required.
- Is this a product approval, provision plan or research protocol?
- Does the pathway cover my diagnosis and proposed procedure?
- Can I receive translated consent and follow-up instructions?
Compare the Thai proposal using the same standard
Request the exact product, diagnosis, responsible clinician and applicable Thai authorisation or research pathway. Do not transfer a foreign permission to treatment in Thailand. Read the Thai legal-status checklist and obtain the documents for the proposed date and place of care.
Compare complete costs and travel
For a Japan visit, clarify which records require translation and who checks their accuracy. Ask whether collection, preparation and administration require separate trips. Compare the resulting schedule and accommodation needs with Thailand before booking.
Ask for an itemised estimate in Japanese yen and an equivalent Thai estimate in baht. Record the date and exchange rate if converting totals, plus payment fees. No verified matching price dataset is available here, so this guide does not claim that either country is cheaper.
Compare cancellation terms, excluded care and the cost of additional visits. Use cost planning and insurance questions.
Make the final decision around the care plan
Give both plans to a clinician familiar with your diagnosis. Ask which evidence applies, what uncertainties remain and whether travelling adds value over care available locally. Establish who will review outcomes and manage problems after the trip.
Which country has the better success rate?
No comparable audited country-wide dataset is presented here. Outcomes need to be matched by product, condition and follow-up.
Does this comparison confirm I can receive treatment?
No. Availability, eligibility and authorisation require direct confirmation for the exact intervention.
Ask about an assessment
For questions about the review process, availability or a written estimate, message Thailand Stem Cell Clinic. Ask how to share records securely. An enquiry does not confirm eligibility or that a particular treatment is offered.
All comparisons · Treatment guides · Contact information
Sources and further reading
General information, not an individual medical recommendation. Prices, coverage, eligibility and authorisation require case-specific confirmation. Source links describe their own research and jurisdictions.